Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Standard Medication”

360 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 360 results

Early research (Phase 1)Ended earlyNCT01705106
What this trial is testing

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Chicago 21
Not applicableEnded earlyNCT02030444
What this trial is testing

Extensive Staging in Lung Cancer

Who this might be right for
Lung Neoplasms
St. Olavs Hospital 32
Post-approval studies (Phase 4)UnknownNCT02282085
What this trial is testing

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
Matt Byerly 200
Large-scale testing (Phase 3)Study completedNCT04209114
What this trial is testing

Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Who this might be right for
Bladder CancerBladder TumorMuscle-Invasive Bladder Cancer
Bristol-Myers Squibb 114
Not applicableActive Not RecruitingNCT06387433
What this trial is testing

Effectiveness of an mHealth Mobile App

Who this might be right for
Type II Diabetes
Dow University of Health Sciences 160
Testing effectiveness (Phase 2)Study completedNCT02114684
What this trial is testing

Improving Retreatment Success (IMPRESS)

Who this might be right for
Recurrent Tuberculosis
Centre for the AIDS Programme of Research in South Africa 197
Testing effectiveness (Phase 2)UnknownNCT03448510
What this trial is testing

Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction

Who this might be right for
Lower Urinary Tract Symptoms
Changhai Hospital 100
Not applicableStudy completedNCT00218881
What this trial is testing

An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial

Who this might be right for
HIV Counseling and TestingHIV Infections
North Bronx Healthcare Network 408
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Testing effectiveness (Phase 2)Study completedNCT00556504
What this trial is testing

The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C
TCM Biotech International Corp. 84
Post-approval studies (Phase 4)Study completedNCT00304421
What this trial is testing

Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD

Who this might be right for
Gastroesophageal Reflux Disease
VA Greater Los Angeles Healthcare System 23
Testing effectiveness (Phase 2)Looking for participantsNCT07259226
What this trial is testing

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

Who this might be right for
Advanced Breast CancerAdvanced Gastric CancerAdvanced Urothelial Cancer+1 more
UNICANCER 400
Post-approval studies (Phase 4)Study completedNCT00659997
What this trial is testing

Efficacy Albendazole and Levamisole Against STH on Unguja

Who this might be right for
AscariasisTrichuriasis
Natural History Museum, United Kingdom 20
Not applicableActive Not RecruitingNCT06010914
What this trial is testing

Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Bayer 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07043036
What this trial is testing

Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or Changing Advanced Therapy

Who this might be right for
IBD
Resilience 116
Testing effectiveness (Phase 2)Study completedNCT05829187
What this trial is testing

Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency

Who this might be right for
Uncomplicated Plasmodium Falciparum
Syamsudin Abdillah,Ph.D, Pharm D 36
Post-approval studies (Phase 4)Study completedNCT00844272
What this trial is testing

Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment

Who this might be right for
Intravenous Drug AbuseChronic Hepatitis C
Universitätsklinikum Hamburg-Eppendorf 189
Large-scale testing (Phase 3)Not Yet RecruitingNCT07365995
What this trial is testing

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
BioNTech SE 736
Not applicableStudy completedNCT00001601
What this trial is testing

Evaluation and Treatment of Oral Soft Tissue Diseases

Who this might be right for
Aphthous StomatitisBurning Mouth SyndromeLichen Planus+2 more
National Institute of Dental and Craniofacial Research (NIDCR) 999
Testing effectiveness (Phase 2)Active Not RecruitingNCT04037254
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+4 more
NRG Oncology 22
Load More Results